“…Bioactive molecules such as proteins, − microRNAs (miRNAs), − and peptides, , as indispensable components of cells and tissues, play a crucial role in cell proliferation, tissue differentiation, and body metabolism. Studies have found that tumor progression and prognosis are accompanied by abnormal changes in the expression levels of more than one bioactive substance. − For example, miRNAs are important regulators of most physiological processes, and their dysregulated expressions are related to cancer and other pathological diseases. − Meanwhile, glutathione (GSH), as one of the most plentiful endogenous antioxidants against free radicals and toxins, has been shown to be significantly upregulated in various cancer cells. − So far, various strategies have been reported for miRNA or GSH detection, such as CRISPR systems, colorimetry, the quantitative polymerase chain reaction, and fluorescence. − However, these existing methods are usually restricted to the analysis of a single biomarker or the same type of different biomarkers, which could no longer meet the growing demand for the early ultrasensitive clinical diagnosis of cancer. Therefore, it is of great significance to develop an ultrasensitive biosensor to monitor different types of biomarkers and further provide more precise and comprehensive data guidance for cancer diagnosis and clinical decision making.…”